Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

被引:399
作者
Ofek, G
Tang, M
Sambor, A
Katinger, H
Mascola, JR
Wyatt, R
Kwong, PD
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Univ Agr Sci, Inst Appl Microbiol, Vienna, Austria
关键词
D O I
10.1128/JVI.78.19.10724-10737.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal region of the ectodomain of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1) is the target of three of the five broadly neutralizing anti-HIV-1 antibodies thus far isolated. We have determined crystal structures of the antigen-binding fragment for one of these antibodies, 2F5, in complex with 7-mer, 11-mer, and 17-mer peptides of the gp41 membrane-proximal region, at 2.0-, 2.1-, and 2.24 resolutions, respectively. The structures reveal an extended gp41 conformation, which stretches over 30 Angstrom in length. Contacts are made with five complementarity-determining regions of the antibody as well as with nonpolymorphic regions. Only one exclusive charged face of the gp41 epitope is bound by 2F5, while the nonbound face, which is hydrophobic, may be hidden due to occlusion by other portions of the ectodomain. The structures reveal that the 2F5 antibody is uniquely built to bind to an epitope that is proximal to a membrane surface and in a manner mostly unaffected by large-scale steric hindrance. Biochemical studies with proteoliposomes confirm the importance of lipid membrane and hydrophobic context in the binding of 2F5 as well as in the binding of 4E10, another broadly neutralizing antibody that recognizes the membrane-proximal region of gp41. Based on these structural and biochemical results, immunization strategies for eliciting 2F5- and 4E10-like broadly neutralizing anti-HIV-1 antibodies are proposed.
引用
收藏
页码:10724 / 10737
页数:14
相关论文
共 70 条
  • [41] CROSS-NEUTRALIZING ACTIVITY AGAINST DIVERGENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES INDUCED BY THE GP41 SEQUENCE ELDKWAS
    MUSTER, T
    GUINEA, R
    TRKOLA, A
    PURTSCHER, M
    KLIMA, A
    STEINDL, F
    PALESE, P
    KATINGER, H
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (06) : 4031 - 4034
  • [42] A CONSERVED NEUTRALIZING EPITOPE ON GP41 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    MUSTER, T
    STEINDL, F
    PURTSCHER, M
    TRKOLA, A
    KLIMA, A
    HIMMLER, G
    RUKER, F
    KATINGER, H
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (11) : 6642 - 6647
  • [43] PROTEIN FOLDING AND ASSOCIATION - INSIGHTS FROM THE INTERFACIAL AND THERMODYNAMIC PROPERTIES OF HYDROCARBONS
    NICHOLLS, A
    SHARP, KA
    HONIG, B
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1991, 11 (04) : 281 - 296
  • [44] Processing of X-ray diffraction data collected in oscillation mode
    Otwinowski, Z
    Minor, W
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 307 - 326
  • [45] PAI EF, 2000, Patent No. 0061618
  • [46] Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
    Pantophlet, R
    Wilson, IA
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 5889 - 5901
  • [47] Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5
    Parker, CE
    Deterding, LJ
    Hager-Braun, C
    Binley, JM
    Schülke, N
    Katinger, H
    Moore, JP
    Tomer, KB
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (22) : 10906 - 10911
  • [48] PARREN PWHI, 1995, AIDS, V9, pF1, DOI 10.1097/00002030-199506000-00001
  • [49] A BROADLY NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY AGAINST GP41 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PURTSCHER, M
    TRKOLA, A
    GRUBER, G
    BUCHACHER, A
    PREDL, R
    STEINDL, F
    TAUER, C
    BERGER, R
    BARRETT, N
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1651 - 1658
  • [50] Restricted antigenic variability of the epitope recognized by the neutralizing gp41 ant body 2F5
    Purtscher, M
    Trkola, A
    Grassauer, A
    Schulz, PM
    Klima, A
    Dopper, S
    Gruber, G
    Buchacher, A
    Muster, T
    Katinger, H
    [J]. AIDS, 1996, 10 (06) : 587 - 593